Loading clinical trials...

The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage | Clinical Trials | Clareo Health

NOT_YET_RECRUITING

The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage

NCT06535438•Jin Hu

View on ClinicalTrials.gov

Summary

The goal of this observational study is to To investigate the ability of Noncontrast Computed Tomography to predict clinical prognosis in Intracerebral Hemorrhage. The main question it aims to answer is:How to judge the prognosis of patients with cerebral hemorrhage by CT image reading at admission.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Age≥18 years
•2. had completed a CT examination within 24 h of disease onset;
•3. had a hemorrhage that was located in the brain parenchyma, including the basal ganglia, thalamus,brain lobes, brainstem, and cerebellum.

Exclusion Criteria

•1. had secondary ICH caused by brain trauma,cerebrovascular malformations, aneurysms, and tumors;
•2. had ischemic cerebral infarction hemorrhagic transformation;
•3. had undergone surgical treatment (e.g.hematoma removal or puncture drainage) before the CT examination;
•4. had images of poor quality that could notbe accurately evaluated;
•5. had a hematoma withborders that could not be delineated, thus precluding delineation of the region of interest (ROI).

Key Dates

Start Date

August 1, 2024

Primary Completion Date

August 31, 2024

Completion Date

August 31, 2024

Last Updated

August 2, 2024

Enrollment

1,000

ESTIMATED participants

Conditions

Intracerebral Hemorrhage

Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control

NCT07458880

Intracerebral Hemorrhage

View study

RECRUITINGNA

Evaluating a Prototype CT Scan for ICH Evacuation

NCT07455201

Intracerebral Hemorrhage

View study

RECRUITING

Hemodynamic ABI Monitor

NCT06725108

Traumatic Brain Injury (TBI)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Role of Noncontrast Computed Tomography Markers in Predicting the Clinical Outcome of Cerebral Hemorrhage

Inclusion Criteria

Exclusion Criteria

Triple Antihypertensive Medication After Intracerebral Hemorrhage for Blood Pressure Control

Evaluating a Prototype CT Scan for ICH Evacuation

Hemodynamic ABI Monitor

Short-term And Longer-term Cognitive Impact Of Neurochecks

Dutch Intracerebral Hemorrhage Surgery Trial

Cerebrovascular Disease: Quality of Life (CODE: QoL)